Vivos (RDGL) Non Operating Income (2010 - 2025)
Vivos (RDGL) reported Non Operating Income of $17205.0 for Q4 2025, up 104.76% on a YoY basis from $8402.5 in Q4 2024, and down 27.49% sequentially from $23729.0 in Q3 2025.
Vivos (RDGL) Non Operating Income (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Non Operating Income data on file, last reported at $17205.0 in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income rose 104.76% year-over-year to $17205.0; the trailing twelve-month figure through Dec 2025 stood at $99029.0 (up 132.36% YoY), and the FY2025 full-year result was $99030.0, up 132.36% from the prior year.
- Non Operating Income slipped to $17205.0 in Q4 2025, from $23729.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $47588.0 in Q1 2022 to a low of -$361388.0 in Q4 2024.
- A 5-year average of -$17938.9 and a median of $18236.0 in 2024 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income jumped 688.81% in 2021 and plunged 170.85% in 2024, its largest moves.
- Tracing RDGL's Non Operating Income over 5 years: stood at $40210.0 in 2021, then rose by 18.35% to $47588.0 in 2022, then plunged by 380.38% to -$133428.0 in 2023, then slumped by 170.85% to -$361388.0 in 2024, then soared by 104.76% to $17205.0 in 2025.
- Business Quant data shows RDGL's Non Operating Income at $17205.0 in Q4 2025, $23729.0 in Q3 2025, and $29259.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | - |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | 17,205.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,205.00 |
| Sep 30, 2025 | 23,729.00 |
| Jun 30, 2025 | 29,259.00 |
| Mar 31, 2025 | 28,836.00 |
| Dec 31, 2024 | -361,388.00 |
| Sep 30, 2024 | 17,882.00 |
| Jun 30, 2024 | 18,851.00 |
| Mar 31, 2024 | 18,590.00 |
| Dec 31, 2023 | -133,428.00 |
| Sep 30, 2023 | 19,943.00 |
| Jun 30, 2023 | 11,879.00 |
| Mar 31, 2022 | 47,588.00 |
| Dec 31, 2021 | 40,210.00 |
| Sep 30, 2021 | -6,577.00 |
| Jun 30, 2021 | -6,502.00 |
| Mar 31, 2021 | -53,099.00 |
| Dec 31, 2020 | -6,829.00 |
| Sep 30, 2020 | -7,151.00 |
| Jun 30, 2020 | -30,634.00 |
| Mar 31, 2020 | -239,858.00 |